SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S13 - Motor Neuron Diseases: Biomarkers, Outcome Measures, and Therapeutics

Event Time: Monday April 24, 2017 1:00 pm to 3:00 pm
Topic(s): Neuromuscular and Clinical Neurophysiology (EMG)
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Georgios Manousakis MD 
2:35 PM - 3:00 PM Discussion David Walk MD 

Disclosures

Speaker Disclosure
Georgios Manousakis, MD Dr. Manousakis has nothing to disclose.

David Walk, MD Acceleron Pharma editor, Pain Medicine . . . . .

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Experience with pre-existing anti-AAV9 antibody in the SMA1 population Douglas M. Sproule, MD
Disclosure:
Dr. Sproule has received personal compensation for activities with AveXis, Inc. as an employee. Dr. Sproule holds stock and/or stock options with AveXis, Inc.

1:12 PM 002 AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Correlation between CHOP-INTEND and Motor Milestone achievements Linda Lowes
Disclosure:
Dr. Lowes has received personal compensation for activities with AveXis, Inc., Bristol-Myers Squibb, Sarepta Therapeutics, and Pfizer as a consultant. Dr. Lowes has received royalty payments from ACTIVE physical assessment system.

1:24 PM 003 A placebo-controlled study to evaluate the safety, tolerability, and preliminary efficacy of BVS857 in patients with spinal and bulbar muscular atrophy Christopher Grunseich, MD
Disclosure:
Dr. Grunseich has nothing to disclose.

1:36 PM 004 Reliability of functional outcome measures in spinal muscular atrophy: Results from multi-centered, global, phase 3 clinical trials Allan Glanzman
Disclosure:
Dr. Glanzman has received personal compensation for activities with Biogen as an advisory board member.

1:48 PM 005 Tracking longitudinal evolution of amyotrophic lateral sclerosis using multimodal MRI Pilar Maria Ferraro
Disclosure:
Dr. Ferraro has nothing to disclose.

2:00 PM 006 Multimodal structural MRI in the diagnosis of motor neuron diseases Federica Agosta
Disclosure:
Ms. Agosta has received personal compensation for activities with EXCEMED – Excellence in Medical Education as a speaker.

2:12 PM 007 Patient Activity of Daily Living for Amyotrophic Lateral Sclerosis Laura Herbelin
Disclosure:
Dr. Herbelin has nothing to disclose.

2:24 PM 008 Phenotypic heterogeneity in Italian patients with motor neuron disease Nicola Ticozzi, MD
Disclosure:
Dr. Ticozzi has nothing to disclose.

Register Now

Related Courses

Sunday April 22, 2018

7:00 AM-9:00 AM
C30 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Michael Shy MD
1:00 PM-3:00 PM
C40 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Michael Shy MD
1:00 PM-5:30 PM
C47 Neuromuscular Ultrasound Skills Workshop (Registration Required) Craig Zaidman MD
3:30 PM-5:30 PM
C54 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Michael Shy MD

Tuesday April 24, 2018

1:00 PM-5:30 PM
C119 EMG Skills Workshop: Basic Ezgi Tiryaki MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C142 Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
1:00 PM-3:00 PM
C155 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
3:30 PM-5:30 PM
C169 Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C179 Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
1:00 PM-3:00 PM
C192 Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Mark Bromberg MD, PhD, FAAN
3:30 PM-5:30 PM
C206 Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
6:30 PM-9:30 PM
C210 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease Anne Connolly MD, FAAN

MEMBER LOG IN

Forgot Password?